medical research
Building a Better Biobank- Investing in the Future
April 16 by Pharmaceuticals & Biotechnology EditorThe biobanking landscape is changing rapidly to deal with the increasing demands of the systems biology community. The UK Biobank highlights the continuing advances in the research field with the...
Consent Critical to Building Public Support for Biobanks?
August 04 by Pharma IQEver-increasing demand for personalised medicine has enhanced the global requirement for biobanks to provide human tissue, body fluids and their derivatives. Between the two distinct types of bio...
Pharma IQ Exclusive with CDISC's Rebecca Kush: The Role of the Clinical Data Manager in an Automated e-Future
July 28 by Pharmaceuticals & Biotechnology EditorRebecca Daniels Kush, Ph.D. is a Founder and the current President and CEO of CDISC, speaks to Andrea Chares from Pharma IQ, about how eSource guidance is generating a lot of discussion and opp...
Biobanking: Current Failures and New Models of Consent
April 19 by Kieran O’DohertyKieran O’Doherty, Assistant Professor at the University of Guelph, joins Pharma IQ to discuss current failures and new models of consent in biobanking. Pharma IQ: Thanks for joining us. Now...